Proceedings of the 44th Annual General Meeting of the Company held on September 30, 2026

September 30, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, P.J. Towers, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code : 506109 Symbol : GENESYS Dear Sir/Madam, Subject: Summary of proceedings of 44th Annual General Meeting of the Company held on September 30, 2026 Pursuant to the requirement of the regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, from time to time, Please find enclosed herewith the summary of proceedings of the 44th Annual General Meeting (AGM) of the Genesys International Corporation Limited held on today i.e., Wednesday, September 30, 2026 at 03:30 P.M. through Video Conferencing/Other Audio Visual Means to transact the business as mentioned in the notice. You are requested to take the above information on records. Thanking You, Yours faithfully, For Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 Gist of the Proceeding’s of the 44th Annual General Meeting (‘the Meeting’/’AGM’) of Genesys International Corporation Limited 1. Date, time and venue of the Meeting: The 44th AGM of the members of the Company was held on Wednesday, September 30, 2026 at 03:30 P.M. through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) in compliance with the relevant circulars issued by the Ministry of Corporate Affairs (“MCA”) and the Securities and Exchange Board of India (“SEBI”). 2. Proceedings in brief: Mr. Sajid Malik, Chairman and Managing Director of the Company took the Chair and welcomed the members. He declared that the requisite quorum was present at the meeting and called the Meeting to order. The Chairman welcomed all the Directors and requested them to introduce themselves to the Members. The Directors present at the meeting introduced themselves. The Chairperson of the Audit Committee, Stakeholder Relationship Committee and Nomination and Remuneration Committee, Chief Executive Officer, Chief Financial Officer and the Company Secretary were also present at the Meeting. The Company Secretary provided general instructions to the members of the Company regarding participation and e-voting facility to exercise their right to vote. He informed that the shareholders who could not cast their vote through remote e-voting process can still cast their vote at the AGM. He also informed the Members that the proceedings of the Meeting were video recorded. Mr. Sanam Umbargikar, Partner of M/s DSM & Associates, Practicing Company Secretary, was appointed as Scrutinizer for the e-voting process. It was informed to the Members that the Statutory Auditor's Report on the standalone and consolidated financial statements for the financial year ended March 31, 2026 does not contain any qualification, observation or comment on financial transactions or matters having any adverse effect on the functioning of the Company. The Secretarial Audit Report for the financial year ended March 31, 2026 also does not contain any qualification, reservation, observation, adverse remark or disclaimer having a material adverse effect on the functioning of the Company. Accordingly, there are no such qualifications, observations, comments or remarks required to be read at this Meeting The Notice of Annual General Meeting was already circulated to all the members, hence the same was taken as read. Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 Following items of business as per the Notice of 44th Annual General Meeting were transacted. Particulars Type of Resolution Ordinary Business 1(A). To consider and adopt the Audited Financial Statements Ordinary Resolution of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon; and 1(B.) To consider and adopt the Audited Consolidated Ordinary Resolution Financial Statements of the Company for the financial year ended March 31, 2026 and the report of Auditors thereon. 2. To appoint Dr. Yogita Shukla (DIN: 09286545), who retires Ordinary Resolution by rotation, as a director 3. To appoint the Statutory Auditors of the Company and Ordinary Resolution fix their remuneration. Special Business 4. Approval of Genesys International Corporation Limited Special Resolution – Employee Stock Option Plan (Genesys ESOP Scheme 2026). 5. Grant of Stock Options to the employees of Subsidiary, Special Resolution Associates Company/ ies under “GENESYS ESOP SCHEME - 2026” 6. Approval for the variation/change in the objects of the Special Resolution Qualified Institutions Placement (QIP) issue as stated in the Placement Document dated May 17, 2025. The Chairman then invited the Members to raise their questions. The Members raised their queries, which were duly answered by the Chairman. The Chairman thanked the Members for their continuous support and for attending and participating in the Meeting. The Company Secretary informed the Members that the evoting facility would remain open for the next 15 minutes after conclusion of the meeting. The voting results shall be intimated to the Stock Exchanges subsequent to receipt of Scruitinizer’s Report within the prescribed time. You are requested to take the above on records. Thanking You, For Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197